<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><description>让药物创造变得容易！我们致力于成为中国健康产业的传播者、服务者、推动者。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 25 Apr 2021 13:29:22 +0800</pubDate><image><url>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</url><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>363个品种一网打尽？带量采购超级大联盟飓风袭来？！</title><link>https://mp.weixin.qq.com/s/HjINN2D3gDOkWx3heJ5Qqg</link><description></description><content:encoded><![CDATA[363个品种一网打尽？带量采购超级大联盟飓风袭来？！]]></content:encoded><pubDate>Sun, 25 Apr 2021 11:52:48 +0800</pubDate></item><item><title>全球医药创新指数榜单出炉！礼来夺冠，4家创新药企首次上榜，百济神州、Moderna…</title><link>https://mp.weixin.qq.com/s/aPwvYCkguWI5xXG9_xX2gA</link><description></description><content:encoded><![CDATA[全球医药创新指数榜单出炉！礼来夺冠，4家创新药企首次上榜，百济神州、Moderna…]]></content:encoded><pubDate>Sun, 25 Apr 2021 11:52:48 +0800</pubDate></item><item><title>【药咖君】不限癌种PD-1报上市！糖尿病一周一次新药即将获批，“药王”再获批新适应症，复宏汉霖、恒瑞、石药…</title><link>https://mp.weixin.qq.com/s/akNJ-7SWxz-bXAvfgp6bXw</link><description></description><content:encoded><![CDATA[【药咖君】不限癌种PD-1报上市！糖尿病一周一次新药即将获批，“药王”再获批新适应症，复宏汉霖、恒瑞、石药…]]></content:encoded><pubDate>Sun, 25 Apr 2021 11:52:48 +0800</pubDate></item><item><title>药企带金销售，中纪委点名了</title><link>https://mp.weixin.qq.com/s/BV5IuIhwcA98j4bnK4YuGA</link><description></description><content:encoded><![CDATA[药企带金销售，中纪委点名了]]></content:encoded><pubDate>Sun, 25 Apr 2021 11:52:48 +0800</pubDate></item><item><title>瞄准3100亿眼科“大蛋糕”：诺华、参天巨头血拼，黄金赛道竞争白热化</title><link>https://mp.weixin.qq.com/s/dmtan_9vEpFfVN8IUX0LoA</link><description></description><content:encoded><![CDATA[瞄准3100亿眼科“大蛋糕”：诺华、参天巨头血拼，黄金赛道竞争白热化]]></content:encoded><pubDate>Fri, 23 Apr 2021 17:50:56 +0800</pubDate></item><item><title>国内药企研发投入TOP榜！百济神州最“豪”，恒瑞、复星、石药最“多”；君实生物、康希诺、康宁杰瑞增长最快，云顶新耀...</title><link>https://mp.weixin.qq.com/s/W4VHWR0iBkW-GDUZvgUf7w</link><description></description><content:encoded><![CDATA[国内药企研发投入TOP榜！百济神州最“豪”，恒瑞、复星、石药最“多”；君实生物、康希诺、康宁杰瑞增长最快，云顶新耀...]]></content:encoded><pubDate>Fri, 23 Apr 2021 11:57:50 +0800</pubDate></item><item><title>重磅！首家中国药企向美国FDA递交舒利迭®仿制药申请</title><link>https://mp.weixin.qq.com/s/-ae-rW_42ay7YWSK9mfydw</link><description></description><content:encoded><![CDATA[重磅！首家中国药企向美国FDA递交舒利迭®仿制药申请]]></content:encoded><pubDate>Fri, 23 Apr 2021 11:57:50 +0800</pubDate></item><item><title>最新：第五批国采品种，将从211报量品规中筛选</title><link>https://mp.weixin.qq.com/s/9SP7e8wDMb2FTWKgKVb3qw</link><description></description><content:encoded><![CDATA[最新：第五批国采品种，将从211报量品规中筛选]]></content:encoded><pubDate>Fri, 23 Apr 2021 11:57:50 +0800</pubDate></item><item><title>重磅！全国医药大检查，开始</title><link>https://mp.weixin.qq.com/s/j6cp49ynQSCz1mVhA4rgSw</link><description></description><content:encoded><![CDATA[重磅！全国医药大检查，开始]]></content:encoded><pubDate>Fri, 23 Apr 2021 11:57:50 +0800</pubDate></item><item><title>首战即决战？广东常态化带量采购“慌”了企业</title><link>https://mp.weixin.qq.com/s/SHpt2DTFSCVLhpl6uZBoNA</link><description></description><content:encoded><![CDATA[首战即决战？广东常态化带量采购“慌”了企业]]></content:encoded><pubDate>Thu, 22 Apr 2021 10:23:17 +0800</pubDate></item><item><title>全球顶尖「医疗生态创新实验室」Top10：嘉德诺、BJC医疗、谷歌…</title><link>https://mp.weixin.qq.com/s/Gh4zBEeK-VYPUJMMyNJLeA</link><description></description><content:encoded><![CDATA[全球顶尖「医疗生态创新实验室」Top10：嘉德诺、BJC医疗、谷歌…]]></content:encoded><pubDate>Thu, 22 Apr 2021 10:23:17 +0800</pubDate></item><item><title>免费参会！药智巡讲济南站《2021改良型新药研发前沿论坛》</title><link>https://mp.weixin.qq.com/s/NNqG96D5mKmFiagyo8harg</link><description></description><content:encoded><![CDATA[免费参会！药智巡讲济南站《2021改良型新药研发前沿论坛》]]></content:encoded><pubDate>Thu, 22 Apr 2021 10:23:17 +0800</pubDate></item><item><title>知名药企，裁撤销售团队</title><link>https://mp.weixin.qq.com/s/qVx9_4BatlbUydF9bcb-Dw</link><description></description><content:encoded><![CDATA[知名药企，裁撤销售团队]]></content:encoded><pubDate>Thu, 22 Apr 2021 10:23:17 +0800</pubDate></item><item><title>恒瑞医药：2020年业绩不及预期，又要面临集采重压</title><link>https://mp.weixin.qq.com/s/0XyPBfJC36xVdKH2amxlRg</link><description></description><content:encoded><![CDATA[恒瑞医药：2020年业绩不及预期，又要面临集采重压]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:26:31 +0800</pubDate></item><item><title>NMPA发布2020年成绩单！1096个创新药获批临床，20个获批生产...</title><link>https://mp.weixin.qq.com/s/6lXgf6EBTpwhwp9M1i-f8g</link><description></description><content:encoded><![CDATA[NMPA发布2020年成绩单！1096个创新药获批临床，20个获批生产...]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:26:31 +0800</pubDate></item><item><title>聚智创新·融合发展|2021大健康产业高质量发展大会暨第六届中国医药研发·创新峰会（PDI）</title><link>https://mp.weixin.qq.com/s/Ncti-kaC0frjLaevKQTU-Q</link><description></description><content:encoded><![CDATA[聚智创新·融合发展|2021大健康产业高质量发展大会暨第六届中国医药研发·创新峰会（PDI）]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:26:31 +0800</pubDate></item><item><title>最严合规下，教你两招市场上量！</title><link>https://mp.weixin.qq.com/s/mugZA-Xn3lAgh0xMIM1n1A</link><description></description><content:encoded><![CDATA[最严合规下，教你两招市场上量！]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:26:31 +0800</pubDate></item><item><title>第二批国采到期续约报量开启！这些重点需要关注</title><link>https://mp.weixin.qq.com/s/CY40fSjjMX2hzVdstVDpiw</link><description></description><content:encoded><![CDATA[第二批国采到期续约报量开启！这些重点需要关注]]></content:encoded><pubDate>Tue, 20 Apr 2021 16:34:10 +0800</pubDate></item><item><title>安进新药获FDA突破性疗法认定！曾让Five Prime股价暴涨300%</title><link>https://mp.weixin.qq.com/s/2l7z2QB5vSZ3xK1QqyzAJA</link><description></description><content:encoded><![CDATA[安进新药获FDA突破性疗法认定！曾让Five Prime股价暴涨300%]]></content:encoded><pubDate>Tue, 20 Apr 2021 16:34:10 +0800</pubDate></item><item><title>智飞生物2020年报：新冠疫苗收入有望堪比全年营收，自主产品产销扩大是趋势</title><link>https://mp.weixin.qq.com/s/fcA5ggD37T5Y8gWdeiuOHA</link><description></description><content:encoded><![CDATA[智飞生物2020年报：新冠疫苗收入有望堪比全年营收，自主产品产销扩大是趋势]]></content:encoded><pubDate>Tue, 20 Apr 2021 16:34:10 +0800</pubDate></item></channel></rss>